Sign In
Buy ARDX
$6.18
-0.190 (-2.98%)
At Close: Jun 23, 2026
State Street Corp Boosts Stock Holdings in Ardelyx Inc (NASDAQ:ARDX)
04:34am, Monday, 22'nd Jun 2020
State Street Corp grew its position in shares of Ardelyx Inc (NASDAQ:ARDX) by 30.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (
Hedge Funds Are Dumping Ardelyx Inc (ARDX)
04:45pm, Friday, 19'th Jun 2020
In this article we will take a look at whether hedge funds think Ardelyx Inc (NASDAQ:ARDX) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into ho
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today repo
BNP Paribas Arbitrage SA Acquires 195,902 Shares of Ardelyx Inc (NASDAQ:ARDX)
07:20am, Sunday, 14'th Jun 2020
BNP Paribas Arbitrage SA grew its holdings in shares of Ardelyx Inc (NASDAQ:ARDX) by 3,538.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Excha
Contrasting Merrimack Pharmaceuticals (NASDAQ:MACK) and Ardelyx (NASDAQ:ARDX)
03:10am, Sunday, 14'th Jun 2020
Merrimack Pharmaceuticals (NASDAQ:MACK) and Ardelyx (NASDAQ:ARDX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of th
Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12:45am, Wednesday, 10'th Jun 2020
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 8)
Biohaven Pharmaceutical...
Ardelyx Appoints Veteran Biopharma Executive, Justin Renz, as Chief Financial Officer
08:01pm, Monday, 08'th Jun 2020
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,
Ardelyx: Sales Estimates For Tenapanor Suggest Upside In The Stock (NASDAQ:ARDX)
02:48pm, Sunday, 31'st May 2020
Ardelyx's lead drug, tenapanor for hyperphosphatemia, is estimated to have peak sales up to $782 million and should be on the market by mid-2021. Ardelyx has en
Ardelyx to Present at the Jefferies 2020 Virtual Healthcare Conference
01:00pm, Tuesday, 26'th May 2020
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,
Ardelyx Appoints Susan Rodriguez As Chief Commercial Officer
08:03pm, Monday, 18'th May 2020Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer
08:01pm, Monday, 18'th May 2020
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,
Ikarian Capital, LLC Buys Acceleron Pharma Inc, Verastem Inc, Zogenix Inc, Sells Aptose ...
12:00am, Friday, 15'th May 2020Will Ardelyx Continue to Surge Higher?
02:44pm, Tuesday, 12'th May 2020
As of late, it has definitely been a great time to be an investor Ardelyx
